Please login to the form below

Not currently logged in
Email:
Password:

Cablivi

This page shows the latest Cablivi news and features for those working in and with pharma, biotech and healthcare.

Sanofi swaps execs with Bayer, looks to staunch diabetes, cardio decline

Sanofi swaps execs with Bayer, looks to staunch diabetes, cardio decline

The EMA has just approved its acquired thrombotic thrombocytopenic purpura (aTTP) therapy Cablivi, the main asset behind its 9.3bn acquisition of Belgian biotech Ablynx, with an FDA decision expected in

Latest news

More from news
Approximately 1 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
SpotMe

SpotMe is the leading technology and service provider of enterprise engagement platforms with a focus on live events, virtual and...

Latest intelligence

patients
Retaining reader value in plain language summaries of clinical studies
Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...
Paris
Making Europe a leader in bioscience: boosting trust and opening minds
A vision of Paris as Europe's leading hub for life sciences innovation...

Infographics